SCHEMBL9954779

SCHEMBL9954779

CC(C)CCCCCCCCCCCCCC[CH]C(=O)CCCCCCCCCCCCCCC(C)C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 2/20 0.42
KDM4A O75164 1/20 0.42
PHF8 Q9UPP1 1/20 0.42
KDM2A Q9Y2K7 1/20 0.42
CETP P11597 1/20 0.41
DEGS1 O15121 1/20 0.38
KDM1A O60341 1/20 0.38
BLM P54132 2/20 0.37
MEN1 O00255 1/20 0.37
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
TSHR P16473 1/20 0.37
CYP2C19 P33261 1/20 0.37
PMP22 Q01453 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CNR1 P21554 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21081784 0.81 KDM4C (0.46) KDM4CKDM4APHF8KDM2ACETP
SCHEMBL2587476 0.79 KDM1A (0.40) KDM4CKDM4APHF8KDM2ACETP
SCHEMBL27309465 0.78 KDM4C (0.43) KDM4CKDM4APHF8KDM2ACETP
SCHEMBL8770477 0.78 KDM4C (0.43) KDM4CKDM4APHF8KDM2ACETP
SCHEMBL5583898 0.77 PPARG (0.56) BLMMEN1CYP1A2POLBCYP3A4
SCHEMBL1685059 0.77 PPARG (0.56) BLMMEN1CYP1A2POLBCYP3A4
SCHEMBL10645729 0.77 PPARG (0.56) BLMMEN1CYP1A2POLBCYP3A4
SCHEMBL9868698 0.77 PPARG (0.56) BLMMEN1CYP1A2POLBCYP3A4
SCHEMBL1275698 0.77 KDM1A (0.44) KDM4CKDM4APHF8KDM2ACETP
SCHEMBL1173224 0.77 PPARG (0.56) BLMMEN1CYP1A2POLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2654665-A2 METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH (DE) 2013-10-30 EP disclosed
WO-2012083906-A2 METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY MIKA PHARMA GESELLSCHAFT FÜR DIE ENTWICKLUNG UND VERMARKTUNG PHARMAZEUTISCHER PRODUKTE MBH (DE) 2012-06-28 WO disclosed